Solid Sales Growth
Sonova achieved a 5.9% increase in sales in local currencies, driven by a 7% growth in the Hearing Instruments segment and a 12.5% growth in the Cochlear Implant business.
Positive Market Response to Infinio and Sphere
The Infinio and Sphere platforms have received very positive feedback, with Sphere accounting for over 50% of sales in the initial launch markets, indicating strong demand.
Cochlear Implants Segment Performance
The Cochlear Implants segment showed strong momentum with 12.5% growth, with system sales increasing by 18.2%.
Improved Gross Margin
Gross profit margin improved to 71.9%, up 50 basis points in local currency from last year, benefiting from higher volumes and lower component costs.
Market Share Gains in the U.S.
Sonova gained approximately 5 percentage points in market share in the U.S. commercial market following the launch of Infinio and Sphere.